PARADIGM CAPITAL MANAGEMENT INC/NY – Halozyme Therapeutics, Inc. Transaction History

PARADIGM CAPITAL MANAGEMENT INC/NY portfolio value:

$395,000
portfolio value

PARADIGM CAPITAL MANAGEMENT INC/NY quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -45K $39.54 10K
Q2 2022 share 0.00% 0 shares 41K $44 10K
Q1 2022 share 0.00% 0 shares -3K $39.88 10K
Q4 2021 share 0.00% 0 shares -5K $40.32 10K
Q3 2021 share 0.00% 0 shares -47K $40.68 10K
Q2 2021 share 0.00% 0 shares 37K $45.41 10K
Q1 2021 share 0.00% 0 shares -10K $41.69 10K
Q4 2020 share 0.00% 0 shares 164K $42.71 10K
Q3 2020 share 0.00% 0 shares -5K $26.28 10K
Q2 2020 share 0.00% 0 shares 88K $26.81 10K
Q1 2020 share 0.00% 0 shares 3K $17.99 10K
Q4 2019 share 0.00% 0 shares 22K $17.73 10K
Q3 2019 share 0.00% 0 shares -17K $15.51 10K
Q2 2019 share 0.00% 0 shares 11K $17.18 10K
Q1 2019 share 0.00% 0 shares 15K $16.1 10K
Q4 2018 share 0.00% 0 shares -36K $14.63 10K
Q3 2018 share 0.00% 0 shares 13K $18.17 10K
Q2 2018 share 0.00% 0 shares -27K $16.87 10K
Q1 2018 share 0.00% 0 shares -7K $19.59 10K
Q4 2017 share 0.00% 0 shares 29K $20.26 10K
Q3 2017 share 0.00% 0 shares 46K $17.37 10K
Q2 2017 share 0.00% 0 shares -2K $12.82 10K
Q1 2017 share 0.00% 0 shares 31K $12.96 10K
Q4 2016 share 0.00% 0 shares -22K $9.88 10K
Q3 2016 share 0.00% 0 shares 35K $12.08 10K
Q2 2016 share 0.00% 0 shares -9K $8.63 10K
Q1 2016 share 0.00% 0 shares -78K $9.47 10K